Andrew Perry
Corporate Officer/Principal chez G1 THERAPEUTICS, INC.
Fortune : 304 751 $ au 30/04/2024
Postes actifs de Andrew Perry
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| G1 THERAPEUTICS, INC. | Corporate Officer/Principal | 02/08/2021 | - |
Historique de carrière de Andrew Perry
Anciens postes connus de Andrew Perry
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Corporate Officer/Principal | - | - |
Formation de Andrew Perry
| University of Glasgow | Graduate Degree |
| The University of Sheffield | Graduate Degree |
Statistiques
Internationale
| Royaume-Uni | 4 |
| Etats-Unis | 2 |
Opérationnelle
| Graduate Degree | 2 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| G1 THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Andrew Perry
- Expérience